Pay in 4 interest-free payments of $6.12 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
NEW: Eli Lilly and Company's retatrutide, a first-in-class GIP, GLP-1, and glucagon triple hormone receptor agonist, met all primary and key secondary endpoints in the phase 3 TRIUMPH-4 trial in adults with obesity or overweight and knee osteoarthritis, and without diabetes, as an adjunct to healthy diet and physical activity
Most trials are in Phase 3 (56%)
You can make finer dose adjustments (like stepping from 0.5 mg to 0.75 mg instead of jumping straight to 1.0 mg) and you can use split dosing strategies that pre-filled pens do not allow
Natural Ingredients
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist administered subcutaneously for type 2 diabetes management (Ozempic) and chronic weight management (Wegovy)
:max_bytes(150000):strip_icc()/HowDoesOzempicWork-7e49ed58c8f94ab88adb9dc10e5b7ba6.jpg)
US$ 26.94
US$ 25.99
US$ 28.27
US$ 22.01
US$ 24.33
